CHRNB4 and cancer: The number of cancer-related genes co-expressed with CHRNB4 in the CHRNB4-high group was found to be more than that of the CHRNB4-low group, with odds ratios of 4.71 for ACSN and 1.71 for DisGeNET (Figure 3A).